Perioperative Tranexamic Acid Should Be Considered for Total Joint Arthroplasty Patients Receiving Apixaban for Thromboprophylaxis
Perioperative administration of TXA to TJA patients receiving apixaban reduces the risk of bleeding complications without increasing thromboembolic risk. Arthroplasty surgeons should strongly consider providing TXA to TJA patients receiving apixaban.
Authors
- Sagar Telang (ORCID: https://orcid.org/0000-0001-5242-9093)
- Andrew Dobitsch (ORCID: https://orcid.org/0000-0002-8211-9587)
- Jay R. Lieberman (ORCID: https://orcid.org/0000-0002-1374-8929)
- Jacob R. Ball (ORCID: https://orcid.org/0000-0003-3535-2631)
- Ryan Palmer (ORCID: https://orcid.org/0000-0001-5201-7371)
- Nathanael D. Heckmann (ORCID: https://orcid.org/0000-0003-1293-1702)
Institutions
- University of Southern California (US)
Publication Details
- Journal
- Arthroplasty Today
- Published
- 2024-11-06
- DOI
- https://doi.org/10.1016/j.artd.2024.101548
- Citations
- 2
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.10